KRAS and thyroid nodule: In a study that demonstrated the variety in the molecular profile of 96 surgically resected thyroid nodules, RAS (HRAS, NRAS, KRAS) oncogene mutations were present, either alone or with other mutations in almost one-half of cases (46 of 96 cases; 48%) [57].